India Peripheral Vascular Devices Market Size and Share 2032

Market Overview

The India Peripheral Vascular Devices market is projected to grow from USD 296.38 million in 2023 to USD 576.35 million by 2032, at a compound annual growth rate (CAGR) of 8.67%.

The India Peripheral Vascular Devices market is driven by an increasing prevalence of peripheral artery diseases (PAD) due to rising risk factors such as diabetes, hypertension, and an aging population. Advancements in medical technology, including minimally invasive procedures, are further propelling market growth. The growing demand for innovative vascular devices, such as angioplasty balloons and stents, coupled with the expanding healthcare infrastructure, supports the market's expansion. Additionally, government initiatives and investments aimed at improving healthcare access and affordability contribute to a positive market outlook. Trends such as the development of bioresorbable stents and drug-coated balloons are gaining momentum, providing enhanced treatment options for patients. Increasing awareness about PAD and the need for early detection and treatment are also influencing market dynamics. As healthcare standards improve, the demand for advanced peripheral vascular devices is expected to rise steadily, driving market growth in the coming years.

The India Peripheral Vascular Devices market is characterized by regional variations in demand, with key players focusing on both urban and rural areas to expand their reach. Major metropolitan cities such as Delhi, Mumbai, Bengaluru, and Chennai drive much of the market growth due to their well-established healthcare infrastructure and high demand for advanced treatment options. Key players in the market include Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and Nipro Corporation, among others. These companies are continuously innovating and offering a wide range of peripheral vascular devices, including angioplasty balloons, stents, and catheters, to meet the growing needs of patients suffering from peripheral artery diseases. Additionally, the presence of local players, along with international companies expanding their footprint, is fostering a competitive landscape that encourages technological advancements and increased accessibility to vascular treatments across the country.

Market Insights

• The India Peripheral Vascular Devices market was valued at USD 296.38 million in 2023 and is projected to reach USD 576.35 million by 2032, growing at a CAGR of 8.67%.
• Rising prevalence of Peripheral Artery Disease (PAD) and cardiovascular conditions is significantly driving the market.
• Technological advancements in minimally invasive procedures are shaping market growth and increasing the adoption of peripheral vascular devices.
• Increasing awareness of vascular diseases and the need for early diagnosis are contributing to the market's expansion.
• High cost of advanced devices and regulatory approval delays are major restraints limiting market growth.
• Northern and Western India hold the largest market share, driven by better healthcare infrastructure and urbanization.
• Key players such as Terumo Corporation, Medtronic plc, and Boston Scientific Corporation continue to lead the market through innovation and expanding product portfolios.

Market Drivers

Rising Prevalence of Peripheral Artery Disease (PAD)

The increasing incidence of Peripheral Artery Disease (PAD) is a major driver of the India Peripheral Vascular Devices market. Risk factors such as diabetes, hypertension, and obesity, which are prevalent in the country, are contributing to the growing number of PAD cases. For instance, a study by the Indian Council of Medical Research (ICMR) reported that the prevalence of diabetes in India is projected to reach 101 million by 2030. PAD, which affects a significant portion of the aging population, often requires surgical intervention, leading to a higher demand for peripheral vascular devices like stents, balloons, and catheters. The growing awareness of PAD and its complications is further driving the need for effective treatments.

Technological Advancements in Medical Devices

Technological innovations in the field of peripheral vascular devices are reshaping the market landscape. Minimally invasive procedures, which are less risky and have quicker recovery times compared to traditional surgeries, are becoming increasingly popular. For example, the All India Institute of Medical Sciences (AIIMS) has been utilizing drug-coated balloons and bioresorbable stents to improve treatment outcomes for PAD patients. Innovations such as drug-coated balloons, bioresorbable stents, and improved angioplasty devices have enhanced the effectiveness of treatments, reducing the need for repeat procedures. The continuous development of these advanced devices is fostering greater adoption and contributing to the overall market growth.

Expanding Healthcare Infrastructure

India’s improving healthcare infrastructure is another key driver of the peripheral vascular devices market. Increased government spending on healthcare, along with the establishment of advanced medical facilities, is expanding access to high-quality treatment. For instance, according to the Ministry of Health and Family Welfare, the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) has led to the establishment of new AIIMS and the upgradation of government medical colleges across the country. Urbanization and the rise of private healthcare institutions have further facilitated access to advanced vascular treatment options, creating a favorable environment for the growth of peripheral vascular devices. As healthcare standards improve, the demand for sophisticated vascular devices continues to rise.

Government Initiatives and Awareness Programs

Government initiatives aimed at raising awareness about vascular diseases and improving access to healthcare play a significant role in driving market growth. National health programs focusing on non-communicable diseases (NCDs), including cardiovascular conditions, have led to increased diagnosis and treatment of PAD. Additionally, efforts to improve healthcare affordability and insurance coverage are encouraging more patients to seek early treatment for PAD, which in turn boosts the demand for peripheral vascular devices across the country.

Market Trends

Growing Demand for Minimally Invasive Procedures

One of the key trends in the India Peripheral Vascular Devices market is the increasing preference for minimally invasive procedures. These procedures, which involve smaller incisions and faster recovery times, are gaining popularity among both healthcare professionals and patients. Devices such as angioplasty balloons, stents, and catheters are becoming more advanced and are being used for less invasive surgeries. For instance, a survey conducted by the All India Institute of Medical Sciences (AIIMS) reported that approximately 30% of surgeons continued to use minimally invasive surgery (MIS) techniques during the COVID-19 pandemic. The trend towards minimally invasive treatment options is not only improving patient outcomes but also reducing healthcare costs, further driving the market for peripheral vascular devices.

Advancements in Drug-Eluting and Bioresorbable Devices

The market is seeing a shift towards drug-eluting and bioresorbable devices, which are significantly improving treatment outcomes for PAD patients. Drug-eluting balloons and stents are designed to release medication that helps prevent restenosis, offering long-term benefits and reducing the need for repeat procedures. Bioresorbable stents, which dissolve after serving their purpose, are gaining traction as they eliminate the need for permanent implants. These innovations are enhancing the effectiveness of treatments and addressing the long-term complications associated with traditional vascular devices, making them a growing trend in the market.

Integration of Digital Technologies and Artificial Intelligence

Another emerging trend is the integration of digital technologies and artificial intelligence (AI) into the diagnosis and treatment of peripheral artery diseases. AI-based diagnostic tools and imaging technologies are improving the accuracy of disease detection and helping clinicians make more informed decisions regarding treatment. Additionally, AI is being used to develop predictive models for patient outcomes, further enhancing the efficiency of treatment plans. The integration of digital technologies into vascular device development is driving innovation and expanding the market’s growth potential.

Focus on Personalized Medicine

Personalized medicine is an evolving trend in the India Peripheral Vascular Devices market, where treatments are increasingly tailored to the individual patient’s needs. As the understanding of genetic and lifestyle factors in PAD grows, physicians are adopting more customized approaches to treatment. For example, the Genome India project has sequenced 10,000 genomes from 99 ethnic groups to identify treatments for rare genetic diseases. This trend is pushing the demand for devices that cater to specific patient profiles, such as stents and balloons designed for particular anatomical structures or conditions. The move towards personalized treatments is contributing to more successful outcomes and increasing the adoption of advanced vascular devices in the market.

Market Challenges Analysis

High Cost of Advanced Devices

One of the major challenges facing the India Peripheral Vascular Devices market is the high cost of advanced devices such as drug-eluting stents and bioresorbable devices. While these innovations offer enhanced patient outcomes, their premium prices can be a barrier to widespread adoption, particularly in rural or underserved areas. For instance, the average cost of a drug-eluting stent in India can range from INR 30,000 to INR 50,000. The high cost of these devices can limit access to cutting-edge treatments, especially for patients without adequate insurance coverage or financial resources. This issue is compounded by the fact that India’s healthcare system still faces significant disparities in terms of access to advanced medical technologies, which could hinder the growth potential of the market.

Regulatory and Approval Delays

Another challenge in the India Peripheral Vascular Devices market is the lengthy regulatory approval process for new devices. The approval process for medical devices in India is often slow, which can delay the introduction of innovative products to the market. For example, obtaining approval from the Central Drugs Standard Control Organization (CDSCO) can take several months and involves multiple steps, including classification, application submission, and review. Regulatory hurdles, coupled with the complex certification and testing requirements, create barriers for companies looking to launch new vascular devices in the country. These delays can hinder market growth, especially as competition from other global markets accelerates. Moreover, manufacturers must navigate evolving regulatory standards, which may increase the cost and time required to bring products to market.

Market Opportunities

Growing Healthcare Access and Investment

The India Peripheral Vascular Devices market presents significant opportunities due to the expanding healthcare access and investments in the country. As India continues to develop its healthcare infrastructure, both public and private sectors are increasingly investing in advanced medical technologies. This growing access to healthcare, particularly in tier 2 and tier 3 cities, opens up new markets for peripheral vascular devices. The government’s focus on improving healthcare facilities, along with initiatives such as the Pradhan Mantri Jan Arogya Yojana (PMJAY), which aims to provide affordable healthcare to millions, is expected to create a larger pool of patients seeking treatment for vascular diseases. This will drive demand for advanced vascular devices and expand market opportunities for device manufacturers.

Rising Awareness and Preventive Healthcare Initiatives

With the rise in non-communicable diseases such as cardiovascular conditions, there is a growing opportunity to address the increasing awareness of peripheral artery diseases (PAD). As health education programs and preventive healthcare initiatives become more widespread, patients are becoming more aware of the risks associated with PAD, leading to early detection and treatment. This trend creates an opportunity for market players to offer innovative peripheral vascular devices tailored to the needs of a more informed population. Additionally, as the healthcare sector embraces digital technologies, telemedicine, and AI-based diagnostics, the demand for advanced vascular devices will continue to grow. The adoption of personalized medicine further expands the market potential, as patients seek devices and treatments suited to their specific needs.

Market Segmentation Analysis:

By Type:

The India Peripheral Vascular Devices market can be segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons and stents hold the largest share due to their widespread use in the treatment of Peripheral Artery Disease (PAD). Angioplasty balloons are used to dilate narrowed blood vessels, while stents provide support to keep arteries open. The growing adoption of drug-eluting and bioresorbable stents is also contributing to the market expansion. Catheters and guidewires are essential in guiding procedures and accessing the vascular system. The market for these devices is driven by advancements in minimally invasive procedures, which are becoming the preferred treatment option due to faster recovery and reduced risks. The "Others" segment includes devices such as diagnostic catheters and vascular plugs, which are used in specialized procedures, contributing to market diversity and offering manufacturers opportunities to develop innovative solutions for niche applications.

By End-user:

The market is also segmented based on end-users, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals dominate the market due to their established infrastructure, larger patient base, and comprehensive vascular care services. ASCs are growing in prominence, offering cost-effective, specialized procedures with shorter recovery times, which make them attractive for PAD treatments. These centers are especially popular in urban areas, where there is a higher demand for outpatient vascular interventions. Specialty clinics, focusing on vascular conditions, are also seeing increased demand as patients seek more specialized care. The growth of these end-user segments is closely tied to the increasing awareness of PAD, the rise in demand for minimally invasive procedures, and the overall improvement in healthcare accessibility, particularly in smaller cities and towns. As healthcare delivery models evolve, the demand for peripheral vascular devices across all these end-user segments is expected to continue rising.

Segments:

Based on Type:

• Angioplasty Balloons
• Angioplasty Stents
• Catheters
• Guidewires
• Others

Based on End-user:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Based on the Geography:

• Northern
• Western
• Southern
• Eastern

Regional Analysis

Northern

Northern India holds a significant share of the India Peripheral Vascular Devices market, accounting for approximately 30% of the total market. The region’s dominance can be attributed to the presence of major metropolitan cities like Delhi, Chandigarh, and Lucknow, which house advanced healthcare infrastructure and specialized treatment centers. The rising prevalence of cardiovascular diseases, combined with an increasing geriatric population, drives the demand for peripheral vascular devices in this region. Northern India also benefits from strong government healthcare initiatives aimed at improving access to medical services, which is expected to boost market growth. Furthermore, urban hospitals and diagnostic centers equipped with state-of-the-art technology contribute to a higher rate of adoption of advanced devices, including drug-eluting stents and angioplasty balloons. The region's growing healthcare awareness and high demand for minimally invasive procedures also drive the growth of the peripheral vascular devices market.

Western

Western India holds the second-largest market share, approximately 28%, and includes key states like Maharashtra, Gujarat, and Rajasthan. Mumbai, as the economic hub of India, plays a pivotal role in driving market growth due to its well-developed healthcare infrastructure and numerous private and public healthcare facilities. The demand for peripheral vascular devices is notably high in urban areas, driven by an increasing number of patients with lifestyle diseases such as diabetes, hypertension, and obesity. Additionally, Western India has seen an increase in awareness programs and diagnostic campaigns, leading to higher rates of early diagnosis and treatment for Peripheral Artery Disease (PAD). With numerous hospitals and ambulatory surgical centers (ASCs) equipped with advanced treatment capabilities, this region is poised for continued growth in the vascular devices market, especially in the demand for angioplasty balloons, stents, and catheters.

Southern

Southern India contributes around 25% to the overall market share of peripheral vascular devices in India. The region includes prominent states like Tamil Nadu, Kerala, Karnataka, and Andhra Pradesh, with Chennai, Bengaluru, and Hyderabad acting as major healthcare hubs. The region’s well-established healthcare sector, especially in terms of specialized treatment centers and hospitals, has significantly contributed to the growth of the peripheral vascular devices market. A high incidence of cardiovascular diseases, coupled with a growing preference for minimally invasive surgeries, is increasing the demand for vascular devices. Additionally, Southern India benefits from a rising middle-class population with better access to healthcare services, further driving market growth. The growing trend of advanced vascular procedures, especially in tier-1 and tier-2 cities, is expected to contribute positively to the expansion of the market in this region.

Eastern

Eastern India holds a smaller market share of around 17%, with states like West Bengal, Odisha, Bihar, and Jharkhand playing a crucial role in regional demand. Although this region has a relatively lower market share compared to other regions, there are significant opportunities for growth due to increasing healthcare access and government initiatives aimed at improving healthcare infrastructure. Cities like Kolkata are seeing rapid advancements in healthcare services, with the establishment of more specialized hospitals and diagnostic centers. As awareness of peripheral artery disease (PAD) rises and the population becomes more health-conscious, the demand for peripheral vascular devices is expected to increase. However, challenges such as lower healthcare spending and limited access in rural areas need to be addressed to further boost the market share in this region. As healthcare accessibility improves, Eastern India’s market for peripheral vascular devices is projected to grow steadily in the coming years.

Key Player Analysis

• Terumo Corporation
• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Nipro Corporation
• Cook Medical
• Asahi Intecc Co., Ltd.
• Braun Melsungen AG
• MicroPort Scientific Corporation
• Cardinal Health

Competitive Analysis

The India Peripheral Vascular Devices market is highly competitive, with several leading players striving to maintain their market positions through continuous innovation and expanding their product portfolios. Key players in the market include Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nipro Corporation, Cook Medical, Asahi Intecc Co., Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, and Cardinal Health. Leading manufacturers are investing significantly in research and development to introduce technologically advanced devices, including drug-eluting stents, bioresorbable stents, and cutting-edge catheters that offer improved outcomes for patients. For instance, Terumo Corporation has established a state-of-the-art R&D facility in India to support global product development. Companies are focusing on expanding their product portfolios and enhancing their presence in both urban and rural markets to capture a larger customer base. Strategic collaborations, mergers, and acquisitions are common tactics employed to strengthen market positions and expand distribution networks. Additionally, market players are emphasizing localized manufacturing to reduce production costs and improve accessibility to advanced vascular devices. Innovation in minimally invasive technologies remains a key focus, providing competitive advantages by reducing recovery times and improving procedural success rates. As the demand for peripheral vascular treatments grows, competition will intensify, fostering continuous advancements and further market expansion.

Recent Developments

• In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
• In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD's ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
• In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
• In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The India Peripheral Vascular Devices market exhibits a moderately concentrated structure, with a mix of established multinational corporations and emerging domestic players contributing to its competitive dynamics. The market is characterized by a high degree of technological innovation, with key participants continuously focusing on developing advanced products, including drug-eluting stents, bioresorbable stents, and specialty catheters, to enhance procedural outcomes and patient recovery. A growing emphasis on minimally invasive treatments and personalized healthcare solutions further defines the competitive landscape. Market entry barriers are relatively high due to stringent regulatory requirements, significant R&D investments, and the need for specialized manufacturing facilities. However, increasing healthcare investments and supportive government initiatives in India are encouraging new entrants, leading to heightened competition. Additionally, price sensitivity in the region drives manufacturers to balance innovation with cost-efficiency, making affordability a critical success factor. Strategic partnerships, localized production, and extensive distribution networks are common strategies adopted to strengthen market presence. The rise in cardiovascular diseases and awareness about early diagnosis are expected to further shape the market's growth trajectory, enhancing the focus on both innovation and accessibility. Overall, the market's evolving characteristics highlight the ongoing shift toward advanced technologies and patient-centric solutions, contributing to its dynamic and competitive nature.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

1. The India Peripheral Vascular Devices market is expected to witness significant growth driven by the increasing prevalence of cardiovascular and peripheral artery diseases.
2. Advancements in minimally invasive technologies will continue to enhance procedural efficiency and patient recovery times.
3. Rising awareness about early diagnosis and vascular health will boost demand for innovative treatment solutions.
4. Increasing healthcare expenditure and government initiatives will improve access to advanced vascular devices in both urban and rural areas.
5. Localization of manufacturing will reduce costs and make devices more affordable, expanding market penetration.
6. Strategic collaborations, partnerships, and mergers among manufacturers will strengthen market positioning and innovation capacity.
7. The adoption of bioresorbable stents and drug-coated balloons will drive technological advancements in the market.
8. Growing demand for ambulatory surgical centers and specialized clinics will support the expansion of outpatient vascular treatments.
9. Regulatory reforms aimed at streamlining approvals will encourage faster introduction of new products.
10. Enhanced focus on personalized healthcare solutions will shape future product developments and treatment strategies.